Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?

被引：4

作者：

Duerr, Donat ^{[1
]}

Siciliano, Raffaele Daniele ^{[1
]}

Hummel, Yvonne ^{[1
]}

O'Meara, Alix ^{[1
]}

Hirschi, Anita ^{[1
]}

Burkhard, Roger ^{[1
]}

Honegger, Hanspeter ^{[1
]}

机构：

[1] Stadtspital Triemli, CH-8063 Zurich, Switzerland

来源：

ANNALS OF HEMATOLOGY | 2010年 / 89卷 / 01期

关键词：

DELETION; MANAGEMENT; DEL(5Q);

D O I：

10.1007/s00277-009-0775-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：105 / 106

页数：2

共 44 条

[41] Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression [J].

Goehring, Gudrun ;

Giagounidis, Aristoteles ;

Buesche, Guntram ;

Kreipe, Hans Heinrich ;

Zimmermann, Martin ;

Hellstroem-Lindberg, Eva ;

Aul, Carlo ;

Schlegelberger, Brigitte .

ANNALS OF HEMATOLOGY, 2010, 89 (04) :365-374

[42] Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS) [J].

Symeonidis, Argiris ;

Diamantopoulos, Panagiotis ;

Galanopoulos, Athanasios ;

Kourakli, Alexandra ;

Sazakli, Eleni ;

Hatzimichael, Eleftheria ;

Pagoni, Maria ;

Zikos, Panagiotis ;

Vassilakopoulos, Theodoros P. ;

Gavrilaki, Eleni ;

Bouchla, Anthi ;

Kioumi, Anna ;

Palla, Katerina ;

Kotsianidis, Ioannis ;

Michali, Evridiki ;

Kartassis, Zafiris ;

Katodritou, Eirini ;

Lazaris, Vasileios ;

Vagia, Maria ;

Xanthopoulidis, George ;

Assimakopoulou, Theodora ;

Pontikoglou, Charalampos ;

Dimou, Maria ;

Dalekou-Tsolakou, Maria ;

Liapi, Dimitra ;

Kotsopoulou, Maria ;

Labropoulou, Vassiliki ;

Papoutselis, Menelaos ;

Barmparousi, Despina ;

Vlachaki, Efthymia ;

Kaiafa, Georgia ;

Chandrinou, Eleni ;

Karmas, Panagiotis ;

Terpos, Evangelos ;

Vassilopoulos, George ;

Panayiotidis, Panayiotis ;

Viniou, Nora-Athina ;

Pappa, Vassiliki .

CANCERS, 2025, 17 (09)

[43] An 89-year-old patient with "5q-syndrome": One of the oldest patients treated with lenalidomide. A case report [J].

Capodanno, I. ;

Avanzini, P. .

EUROPEAN GERIATRIC MEDICINE, 2011, 2 (03) :174-176

[44] Long-term follow-up of a patient with 5q31.3 microdeletion syndrome and the smallest de novo 5q31.2q31.3 deletion involving PURA [J].

Bonaglia, Maria Clara ;

Zanotta, Nicoletta ;

Giorda, Roberto ;

D'Angelo, Grazia ;

Zucca, Claudio .

MOLECULAR CYTOGENETICS, 2015, 8

← 1 2 3 4 5 →